RDUS (Radius Recycling Inc.) Earnings per share for the last four quarters

Radius Health (RDUS) - corporate logo

The net income per share YoY ttm chart confirms Radius Recycling, Inc. (RDUS) as a leader in the therapy of metabolic bone pathologies, where patent protection guarantees high margins and the indicator value stands at -125.00. Its own transport fleet optimizes scrap delivery, increasing profitability. Meanwhile, the company mitigates geopolitical risks by redirecting scrap metal exports to the US domestic market.

RDUS radiuspharm.com Net earnings per share (EPS TTM) (02/11/2024 - 02/20/2024)

RDUS (Radius Recycling, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:RDUS (Radius Recycling Inc.)
Core merchandise of Radius Pharmaceuticals

Radius Recycling, Inc. (RDUS) integrates ESG principles into biopharmaceuticals to optimize laboratory resources. By analyzing historical EPS YoY TTM dynamics, an investor assesses the real rate of profit change over the last twelve months. This indicator eliminates quarterly dips, capturing the actual growth rate of earnings per share. A positive trend confirms the effectiveness of ethical management and quality control. Stable growth of this metric indicates the fundamental resilience of the business.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Net earnings per share (EPS TTM) MBX (MBX Biosciences)|Altimmune Corp - Earnings per share for the last twelve months|Aardvark Therapeutics Inc. - Net earnings per share (EPS TTM)|SGMT - Net earnings per share (EPS TTM)|BioAge Labs (BIOA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months biomeafusion.com (BMEA)|Earnings per share for the last twelve months Quince Therapeutics, Inc.|Net earnings per share for the last 12 months Fractyl (GUTS)|Net earnings per share for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Net earnings per one share for the last twelve months|Pluri Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Synlogic Corp|LPCN - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Matinas BioPharma Holdings, Inc. MTNB|SPRB: Net earnings per share (EPS TTM)|Galecto Corp - Earnings per share for the trailing year|CTCX (carmellrx.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) lumos-pharma.com|Net earnings per share (EPS TTM) ONVO